The Irish Medicines in Pregnancy Service (IMPS), is a multidisciplinary service involving collaboration between specialist healthcare professionals in obstetrics, maternal-fetal medicine, midwifery and pharmacy. IMPS aims to support safe and effective use of medicines before, during and after pregnancy through information, advocacy, education and research. Below you will find some archived resources which we have produced or contributed to. Please note, the information contained in these documents was accurate at the time of publication.
Irish Medicines in Pregnancy Service
Our Services
Articles
- Infliximab use in pregnancy or breastfeeding – Implications for infant vaccination. Rotunda GP Connect. Issue V1 (May 2022)
- Ondansetron should remain a potential treatment option for women with hyperemesis gravidarum. Rotunda GP Connect. Issue 008 (Feb 2020)
- The Maternity-Pharmacy Axis- Caring for women before, during and after pregnancy. Dr Claire McCarthy. Irish Pharmacy News (November 2022)
- Caring for Women with Epilepsy in your Pharmacy. Dr Nicola Maher. Irish Pharmacy News (April 2022)
- Safety first is urged with modafinil use. Forum. Journal of the Irish College of General Practitioners (ICGP) (June 2022)
Educational events
- Programme for RCPI/IMPS study day: 2021, 2022, 2023
- Programme for the ENTIS Conference. Dublin 2023
IMPS position statements
- Position Statement on Ondansetron Use in Pregnancy. Irish Medicines in Pregnancy Service (IMPS). (Oct 2019)
- Modafinil and the risk of congenital malformations: Implications for practice. Irish Medicines in Pregnancy Service (IMPS). (Oct 2021)
Other media/Social media
- Immunisation Week – Rotunda Instagram (April 2021)
- Real talk with real mums – Episode 9 Mental Health. Brian Cleary (Nov 2019)